The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes

Thrombosis Research

Volumn 125, Issue 3, 2010, Pages 205-209

  Beaulieu, Lea M ^a   Freedman, Jane E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Megakaryocytes; Platelets; TLR2; TLR4; Toll like Receptors

Indexed keywords

CD14 ANTIGEN; FIBRINOGEN RECEPTOR; OXYGEN RADICAL; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

HEMOSTASIS; IMMUNITY; INFLAMMATION; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOCYTOPOIESIS;

ANIMALS; BLOOD PLATELETS; INFLAMMATION; MEGAKARYOCYTES; MICE; TOLL-LIKE RECEPTORS;

EID: 76949093731     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.11.004     Document Type: Review

References (50)

1. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 5566 (Apr 12 2002) 298-300
2. Medzhitov R., and Janeway Jr. C.A. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9 1 (Feb 1997) 4-9
3. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 6640 (Jul 24 1997) 394-397
4. Wetzler L.M. The role of Toll-like receptor 2 in microbial disease and immunity. Vaccine 21 Suppl 2 (Jun 1 2003) S55-S60
5. Beachey E.H., Chiang T.M., Ofek I., and Kang A.H. Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun 16 2 (May 1977) 649-654
6. Berg M., Offermanns S., Seifert R., and Schultz G. Synthetic lipopeptide Pam3CysSer(Lys)4 is an effective activator of human platelets. Am J Physiol 266 6 Pt 1 (Jun 1994) C1684-C1691
7. Travlos G.S. Normal structure, function, and histology of the bone marrow. Toxicol Pathol 34 5 (2006) 548-565
8. Stohlawetz P., Folman C.C., von dem Borne A.E., Pernerstorfer T., Eichler H.G., Panzer S., et al. Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost 81 4 (Apr 1999) 613-617
9. Pick M., Perry C., Lapidot T., Guimaraes-Sternberg C., Naparstek E., Deutsch V., et al. Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis. Blood 107 8 (Apr 15 2006) 3397-3406
10. Shiraki R., Inoue N., Kawasaki S., Takei A., Kadotani M., Ohnishi Y., et al. Expression of Toll-like receptors on human platelets. Thromb Res 113 6 (2004) 379-385
11. Ward J.R., Bingle L., Judge H.M., Brown S.B., Storey R.F., Whyte M.K., et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost 94 4 (Oct 2005) 831-838
12. Andonegui G., Kerfoot S.M., McNagny K., Ebbert K.V., Patel K.D., and Kubes P. Platelets express functional Toll-like receptor-4. Blood 106 7 (Oct 1 2005) 2417-2423
13. Maratheftis C.I., Andreakos E., Moutsopoulos H.M., and Voulgarelis M. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin Cancer Res 13 4 (Feb 15 2007) 1154-1160
14. Jayachandran M., Brunn G.J., Karnicki K., Miller R.S., Owen W.G., and Miller V.M. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol 102 1 (Jan 2007) 429-433
15. Alves-Filho J.C. Toll-like receptors on platelets: the key for disseminated intravascular coagulation in sepsis?. Thromb Res 115 6 (2005) 537-538
16. Funayama H., Huang L., Sato T., Ohtaki Y., Asada Y., Yokochi T., et al. Pharmacological characterization of anaphylaxis-like shock responses induced in mice by mannan and lipopolysaccharide. Int Immunopharmacol 9 13-14 (2009) 1518-1524
17. Sheu J.R., Hung W.C., Kan Y.C., Lee Y.M., and Yen M.H. Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets. Br J Haematol 103 1 (Oct 1998) 29-38
18. Davis R.B., Meeker W.R., and Mc Q.D. Immediate effects of intravenous endotoxin on serotonin concentrations and blood platelets. Circ Res 8 (Jan 1960) 234-239
19. Tang Y.Q., Yeaman M.R., and Selsted M.E. Antimicrobial peptides from human platelets. Infect Immun 70 12 (Dec 2002) 6524-6533
20. Klinger M.H., and Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22 9 (Sep 2002) 913-922
21. Liu C.Z., Huang H.Y., Tsai P.J., and Shih M.H. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria. Thromb Res 116 2 (2005) 145-155
22. Sjobring U., Ringdahl U., and Ruggeri Z.M. Induction of platelet thrombi by bacteria and antibodies. Blood 100 13 (Dec 15 2002) 4470-4477
23. Loughman A., Fitzgerald J.R., Brennan M.P., Higgins J., Downer R., Cox D., et al. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 57 3 (Aug 2005) 804-818
24. Byrne M.F., Kerrigan S.W., Corcoran P.A., Atherton J.C., Murray F.E., Fitzgerald D.J., et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 124 7 (Jun 2003) 1846-1854
25. Kerrigan S.W., Douglas I., Wray A., Heath J., Byrne M.F., Fitzgerald D., et al. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 100 2 (Jul 15 2002) 509-516
26. Chia J.S., Lin Y.L., Lien H.T., and Chen J.Y. Platelet aggregation induced by serotype polysaccharides from Streptococcus mutans. Infect Immun 72 5 (May 2004) 2605-2617
27. Zeller J.A., Lenz A., Eschenfelder C.C., Zunker P., and Deuschl G. Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler Thromb Vasc Biol 25 7 (Jul 2005) 1519-1523
28. Matera C., Falzarano C., Berrino L., and Rossi F. Effects of tetanus toxin, Salmonella typhimurium porin, and bacterial lipopolysaccharide on platelet aggregation. J Med 23 5 (1992) 327-338
29. Kalvegren H., Majeed M., and Bengtsson T. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease?. Arterioscler Thromb Vasc Biol 23 9 (Sep 1 2003) 1677-1683
30. Kalvegren H., Andersson J., Grenegard M., and Bengtsson T. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors. Eur J Pharmacol 566 1-3 (Jul 2 2007) 20-27
31. Sharma A., Novak E.K., Sojar H.T., Swank R.T., Kuramitsu H.K., and Genco R.J. Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets. Oral Microbiol Immunol 15 6 (Dec 2000) 393-396
32. Pham K., Feik D., Hammond B.F., Rams T.E., and Whitaker E.J. Aggregation of human platelets by gingipain-R from Porphyromonas gingivalis cells and membrane vesicles. Platelets 13 1 (Feb 2002) 21-30
33. Lourbakos A., Yuan Y.P., Jenkins A.L., Travis J., Andrade-Gordon P., Santulli R., et al. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 97 12 (Jun 15 2001) 3790-3797
34. Curtis M.A., Macey M., Slaney J.M., and Howells G.L. Platelet activation by Protease I of Porphyromonas gingivalis W83. FEMS Microbiol Lett 110 2 (Jun 15 1993) 167-173
35. Naito M., Sakai E., Shi Y., Ideguchi H., Shoji M., Ohara N., et al. Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesin but not Rgp proteinase. Mol Microbiol 59 1 (Jan 2006) 152-167
36. Montrucchio G., Bosco O., Del Sorbo L., Fascio Pecetto P., Lupia E., Goffi A., et al. Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb Haemost 90 5 (Nov 2003) 872-881
37. Cognasse F., Hamzeh H., Chavarin P., Acquart S., Genin C., and Garraud O. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 83 2 (Apr 2005) 196-198
38. Aslam R., Speck E.R., Kim M., Crow A.R., Bang K.W., Nestel F.P., et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107 2 (Jan 15 2006) 637-641
39. Shibazaki M., Nakamura M., and Endo Y. Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock. Infect Immun 64 12 (Dec 1996) 5290-5294
40. Clark S.R., Ma A.C., Tavener S.A., McDonald B., Goodarzi Z., Kelly M.M., et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13 4 (Apr 2007) 463-469
41. Scott T., and Owens M.D. Thrombocytes respond to lipopolysaccharide through Toll-like receptor-4, and MAP kinase and NF-kappaB pathways leading to expression of interleukin-6 and cyclooxygenase-2 with production of prostaglandin E2. Mol Immunol 45 4 (Feb 2008) 1001-1008
42. Cognasse F., Lafarge S., Chavarin P., Acquart S., and Garraud O. Lipopolysaccharide induces sCD40L release through human platelets TLR4, but not TLR2 and TLR9. Intensive Care Med 33 2 (Feb 2007) 382-384
43. Cognasse F., Hamzeh-Cognasse H., Lafarge S., Delezay O., Pozzetto B., McNicol A., et al. Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol 141 1 (Apr 2008) 84-91
44. Stahl A.L., Svensson M., Morgelin M., Svanborg C., Tarr P.I., Mooney J.C., et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108 1 (Jul 1 2006) 167-176
45. Rumbaut R.E., Bellera R.V., Randhawa J.K., Shrimpton C.N., Dasgupta S.K., Dong J.F., et al. Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism. Am J Physiol Heart Circ Physiol 290 4 (Apr 2006) H1671-H1679
46. Zhang G., Han J., Welch E.J., Ye R.D., Voyno-Yasenetskaya T.A., Malik A.B., et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 182 12 (Jun 15 2009) 7997-8004
47. Patrignani P., Di Febbo C., Tacconelli S., Moretta V., Baccante G., Sciulli M.G., et al. Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. Blood 107 9 (May 1 2006) 3572-3574
48. Damas J.K., Jensenius M., Ueland T., Otterdal K., Yndestad A., Froland S.S., et al. Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets. J Immunol 177 4 (Aug 15 2006) 2699-2706
49. Blair P., Rex S., Vitseva O., Beaulieu L., Tanriverdi K., Chakrabarti S., et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res 104 3 (Feb 13 2009) 346-354
50. Rex S., Beaulieu L.M., Perlman D.H., Vitseva O., Blair P.S., McComb M.E., et al. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release. Thromb Haemost 102 1 (Jul 2009) 97-110